Waterloo Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15M Sell
2,333
-618
-21% -$335K 0.08% 199
2025
Q4
$1.71M Buy
2,951
+939
+47% +$531K 0.12% 157
2025
Q3
$976K Buy
2,012
+262
+15% +$122K 0.07% 192
2025
Q2
$710K Sell
1,750
-501
-22% -$209K 0.06% 223
2025
Q1
$1.12M Buy
2,251
+355
+19% +$192K 0.1% 168
2024
Q4
$986K Sell
1,896
-382
-17% -$210K 0.1% 162
2024
Q3
$1.41M Sell
2,278
-24
-1% -$14.2K 0.15% 142
2024
Q2
$1.27M Sell
2,302
-73
-3% -$41.8K 0.15% 132
2024
Q1
$1.38M Buy
2,375
+25
+1% +$14K 0.18% 118
2023
Q4
$1.25M Buy
2,350
+1,467
+166% +$710K 0.2% 117
2023
Q3
$447K Buy
883
+72
+9% +$38.4K 0.13% 107
2023
Q2
$423K Sell
811
-31
-4% -$16.7K 0.12% 102
2023
Q1
$485K Buy
+842
New +$475K 0.15% 89

Other funds holding TMO

Waterloo Capital's TMO Position: Q1 2026 in Review

Waterloo Capital reduced its Thermo Fisher Scientific (TMO) stake by 21% in Q1 2026, selling an estimated $335K and leaving 2,333 shares worth $1.15M. The position accounts for 0.08% of the portfolio, ranked #199.

Waterloo Capital first reported a position in TMO in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.71M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Waterloo Capital held 2,333 shares of Thermo Fisher Scientific worth $1.15M as of Q1 2026.
  • Waterloo Capital sold 618 Thermo Fisher Scientific shares in Q1 2026, an estimated $335K.
  • Thermo Fisher Scientific made up 0.08% of Waterloo Capital's portfolio in Q1 2026, its #199 holding.
  • Waterloo Capital first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 13 quarters since.
  • Waterloo Capital's Thermo Fisher Scientific position peaked at $1.71M in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Waterloo Capital's 13F filing for Q1 2026, filed 12 May 2026.